IL1B and cancer: Regular PA stimulates the release of skeletal muscle-derived IL-6, which inhibits the release of pro-inflammatory factors (TNF-α and IL-1β) and promotes the release of the anti-inflammatory factor IL-10, inducing an anti-inflammatory environment and improving health outcomes in cancer survivors (23, 60).